IP Library › Granted Patent US 12,447,256
Granted Patent B2
US 12,447,256 · App. 18/121,192 · Granted Oct 21, 2025

Blood separation by microfluidic acoustic focusing

Inventors: Jason O. Fiering (Boston, MA); Shivshanker Sundaram (Tampa, FL); Andrew Meuller (Somerville, MA)
A61M1/3693A61M1/362A61M1/3678A61M1/3692B01D21/28B01D21/283B01D2221/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,447,256
App. No.
18/121,192
Granted
Oct 21, 2025
Kind
B2
Abstract

Systems and methods for cleansing blood are disclosed herein. The methods include acoustically separating undesirable particles bound to capture particles from formed elements of whole blood. After introducing the capture particles to whole blood containing undesirable particles, the whole blood and capture particles are flowed through a microfluidic separation channel. At least one bulk acoustic transducer is attached to the microfluidic separation channel. A standing acoustic wave, imparted on the channel and its contents by the bulk acoustic transducer, drives the formed elements and undesirable particles bound to capture particles to specific aggregation axes. After aggregating the particles, the formed elements exit the separation channel through a first outlet and are returned to the patient. The undesirable particles, bound to the capture particles, exit through a second outlet and can be discarded to saved for later study.

Claims (13)

1. A method of cleansing blood comprising:

flowing whole blood, including plasma, a plurality of formed elements, and a plurality of undesirable particles, into an inlet of a microfluidic separation channel defined in a thermoplastic;

selecting a wavelength of a standing acoustic wave such that a predetermined width of the microfluidic separation channel is between 30% and 45% of the wavelength of the standing acoustic wave; and

applying the standing acoustic wave transverse to a direction of flow of the whole blood through the microfluidic separation channel such that the plurality of formed elements aggregate toward the axial center of the microfluidic separation channel.

2. The method of claim 1 , wherein the predetermined width of the microfluidic separation channel is between about 30% and about 35% of the wavelength of the standing acoustic wave applied to the microfluidic separation channel.

3. The method of claim 1 , wherein a thickness of a wall of the microfluidic separation channel is between about 35% and about 45% of the wavelength of the standing acoustic wave applied to the microfluidic separation channel.

4. The method of claim 1 , further comprising introducing a plurality of lipid-based capture particles into the whole blood such that the plurality of lipid-based capture particles bind to the plurality of undesirable particles.

5. The method of claim 1 , further comprising collecting the plurality of formed elements of the whole blood at a first outlet positioned at a downstream end of the microfluidic separation channel at about the axial center of the microfluidic separation channel.

6. The method of claim 4 , further comprising collecting the plurality of lipid-based capture particles through at least a second outlet positioned at a downstream end of the microfluidic separation channel adjacent to at least one wall along which the plurality of lipid-based capture particles are aggregated.

7. The method of claim 4 , wherein the plurality of lipid-based capture particles comprise an affinity molecule anchored to a lipid bilayer encapsulating a fluid.

8. The method of claim 4 , wherein introducing the plurality of lipid-based capture particles into the whole blood comprises introducing the plurality of lipid-based capture particles using a capture particle injector before the whole blood reaches a particle migration region of the microfluidic separation channel.

9. The method of claim 4 , further comprising forming the plurality of lipid-based capture particles from a mixture of materials comprising an affinity molecule, a lipid, and a fluid with a density less than about 1 g/cm 3 .

10. The method of claim 9 , wherein forming the plurality of lipid-based capture particles comprises injecting the mixture of materials comprising the affinity molecule, the lipid, and the fluid through a nozzle such that the lipid forms a liposome surrounding a portion of the fluid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2023
From: FIERING, JASON O.; MEULLER, ANDREW
To: THE CHARLES STARK DRAPER LABORATORY, INC.
Reel/Frame 062989/0665 →
Continuity (4)
Division 16236404 · Dec 29, 2018
Continuation 14772216
Provisional Application 61775233 · Mar 8, 2013
Related Publication 20230218813A1 · Jul 13, 2023
References Cited (82)
US 6929750B2 · Laurell et al. · 2005 [cited by applicant]
US 7727723B2 · Pollack et al. · 2010 [cited by applicant]
US 7815871B2 · Pamula et al. · 2010 [cited by applicant]
US 7816121B2 · Pollack et al. · 2010 [cited by applicant]
US 7901947B2 · Pollack et al. · 2011 [cited by applicant]
US 8083068B2 · Kaduchak et al. · 2011 [cited by applicant]
US 9731062B2 · Fiering et al. · 2017 [cited by applicant]
US 10099002B2 · Sun et al. · 2018 [cited by applicant]
US 10166323B2 · Fiering et al. · 2019 [cited by applicant]
US 20020009015A1 · Laugharn et al. · 2002 [cited by applicant]
US 20020058273A1 · Shipwash · 2002 [cited by applicant]
US 20030150792A1 · Koehler et al. · 2003 [cited by applicant]
US 20030175947A1 · Liu et al. · 2003 [cited by applicant]
US 20040005582A1 · Shipwash · 2004 [cited by applicant]
US 20040069717A1 · Laurell et al. · 2004 [cited by applicant]
US 20040091398A1 · Gilbert et al. · 2004 [cited by applicant]
US 20040109793A1 · McNeely et al. · 2004 [cited by applicant]
US 20050106064A1 · Laurell et al. · 2005 [cited by applicant]
US 20080154535A1 · Sparks et al. · 2008 [cited by applicant]
US 20080181828A1 · Kluck · 2008 [cited by applicant]
US 20080217259A1 · Siversson · 2008 [cited by applicant]
US 20100006501A1 · Laurell et al. · 2010 [cited by applicant]
US 20100078384A1 · Yang · 2010 [cited by applicant]
US 20100186524A1 · Ariessohn et al. · 2010 [cited by applicant]
US 20100210989A1 · MacPherson et al. · 2010 [cited by applicant]
US 20100317093A1 · Turewicz et al. · 2010 [cited by applicant]
US 20110003303A1 · Pagano et al. · 2011 [cited by applicant]
US 20110014297A1 · Lee et al. · 2011 [cited by applicant]
US 20110034908A1 · Hyde et al. · 2011 [cited by applicant]
US 20110045095A1 · Hettiarachchi et al. · 2011 [cited by applicant]
US 20110136262A1 · Ragavan et al. · 2011 [cited by applicant]
US 20110250585A1 · Ingber et al. · 2011 [cited by applicant]
US 20120122084A1 · Wagner et al. · 2012 [cited by applicant]
US 20120225475A1 · Wagner et al. · 2012 [cited by applicant]
US 20130043170A1 · Rose et al. · 2013 [cited by applicant]
US 20130048565A1 · Fiering et al. · 2013 [cited by applicant]
US 20130085680A1 · Arlen et al. · 2013 [cited by applicant]
US 20130156644A1 · Lee et al. · 2013 [cited by applicant]
US 20140140891A1 · Fiering · 2014 [cited by applicant]
US 20140209542A1 · Spain et al. · 2014 [cited by applicant]
US 20140248621A1 · Collins · 2014 [cited by applicant]
US 20150137015A1 · Toh et al. · 2015 [cited by applicant]
US 20160008532A1 · Fiering et al. · 2016 [cited by applicant]
US 20160030660A1 · Sun et al. · 2016 [cited by applicant]
EP 0914184A1 · 1999 [cited by applicant]
EP 1809399B1 · 2009 [cited by applicant]
EP 2145687A1 · 2010 [cited by applicant]
EP 2352570A2 · 2011 [cited by applicant]
WO WO9846986 · 1998 [cited by applicant]
WO WO0212896A1 · 2002 [cited by applicant]
WO WO0229400 · 2002 [cited by applicant]
WO WO2006032703 · 2006 [cited by applicant]
WO WO2006114596 · 2006 [cited by applicant]
International Preliminary Report on Patentability on PCT Appl. Ser. No. PCT/US2012/052886 dated Mar. 13, 2014 (9 pages). [cited by applicant]
International Preliminary Report on Patentability on PCT Appl. Ser. No. PCT/US2014/022701 dated Sep. 17, 2015 (11 pages). [cited by applicant]
International Preliminary Report on Patentability on PCT Appl. Ser. No. PCT/US2018/029328 dated Nov. 7, 2019 (10 pages). [cited by applicant]
International Search Report and Written Opinion on PCT Appl. Ser. No. PCT/US2012/052886 dated Dec. 11, 2012 (13 pages). [cited by applicant]
International Search Report and Written Opinion on PCT Appl. Ser. No. PCT/US2014/022701 dated Jul. 18, 2014 (16 pages). [cited by applicant]
International Search Report and Written Opinion on PCT Appl. Ser. No. PCT/US2018/029328 dated Jun. 20, 2018 (16 pages). [cited by applicant]
L. Andreas, “Acoustic Standing Wave Manipulation of Particles and Cells in Microfluidic Chips,” Lund University, Jan. 30, 2009, 147 pages. [cited by applicant]
US Final Office Action on U.S. Appl. No. 13/598,401 dated Jul. 1, 2015 (30 pages). [cited by applicant]
US Final Office Action on U.S. Appl. No. 16/236,404 dated Jul. 11, 2022 (18 pages). [cited by applicant]
US Non-Final Office Action on U.S. Appl. No. 13/598,401 dated Jan. 2, 2015 (30 pages). [cited by applicant]
US Non-Final Office Action on U.S. Appl. No. 13/598,401 dated May 20, 2016 (24 pages). [cited by applicant]
US Non-Final Office Action on U.S. Appl. No. 14/815,501 dated Feb. 8, 2018 (7 pages). [cited by applicant]
US Non-Final Office Action on U.S. Appl. No. 15/362,068 dated Jul. 11, 2017 (8 pages). [cited by applicant]
US Non-Final Office Action on U.S. Appl. No. 15/962,420 dated Oct. 3, 2019 (6 pages). [cited by applicant]
US Non-Final Office Action on U.S. Appl. No. 16/236,404 dated Feb. 9, 2022 (16 pages). [cited by applicant]
US Non-Final Office Action on U.S. Appl. No. 16/350,217 dated Oct. 3, 2019 (7 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 13/598,401 dated Jun. 2, 2017 (15 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 14/168,822 dated Aug. 3, 2016 (5 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 14/168,822 dated Mar. 7, 2016 (11 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 14/772,216 dated Aug. 27, 2018 (12 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 14/815,501 dated Jun. 13, 2018 (7 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 15/362,068 dated Jan. 26, 2018 (5 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 16/236,404 dated Feb. 1, 2023 (9 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 16/236,404 dated Oct. 17, 2022 (12 pages). [cited by applicant]
US Notice of Allowance on U.S. Appl. No. 16/350,217 dated Jan. 13, 2020 (7 pages). [cited by applicant]
US Office Action on U.S. Appl. No. 13/598,401 dated Jan. 30, 2017 (33 pages). [cited by applicant]
US Office Action on U.S. Appl. No. 14/772,216 dated Dec. 26, 2017 (13 pages). [cited by applicant]
US Requirement for Restriction/Election on U.S. Appl. No. 14/772,216 dated Jul. 21, 2017 (9 pages). [cited by applicant]
US Requirement for Restriction/Election on U.S. Appl. No. 14/815,501 dated Oct. 4, 2017 (6 pages). [cited by applicant]